Latest News and Press Releases
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Acadia Healthcare Company, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – ACHC
November 27, 2024 16:12 ET
|
The Rosen Law Firm PA
NEW YORK, Nov. 27, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Acadia Healthcare Company, Inc. (NASDAQ: ACHC) between...
Applied Therapeutics Receives Complete Response Letter from U.S. FDA Regarding New Drug Application for Govorestat for Classic Galactosemia
November 27, 2024 16:10 ET
|
Applied Therapeutics
NEW YORK, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a biopharmaceutical company dedicated to creating transformative treatments for rare disease, today announced...
Titan Pharmaceuticals, Inc. Announces Receipt of Notice from Nasdaq
November 27, 2024 16:05 ET
|
Titan Pharmaceuticals, Inc.
NEW YORK, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan”) today reported that it received a notice (the “5250 Notice”) on November 22, 2024 from the Listing...
Globus Maritime Sets Date for the Release of Third Quarter and Nine Months 2024 Results
November 27, 2024 16:05 ET
|
Globus Maritime Limited
GLYFADA, Greece, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Globus Maritime Limited (“Globus” or the “Company”) (NASDAQ: GLBS), a dry bulk shipping company, announced today that it will release financial...
Windtree Therapeutics Reports Third Quarter 2024 Financial Results and Provides Key Business Updates
November 27, 2024 16:05 ET
|
Windtree Therapeutics
WARRINGTON, Pa., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage...
QIAGEN führt neuartige Tools zur Anpassung von digitalen PCR‑Assays und NGS-Panels für die mikrobielle Analyse ein
November 27, 2024 16:05 ET
|
QIAGEN N.V.
VENLO, Niederlande, Nov. 27, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) hat heute die Einführung von zwei neuen Werkzeugen für die Entwicklung und Bestellung von...
Revolution Medicines to Host RAS(ON) Inhibitor Clinical Update Webcast on December 2, 2024
November 27, 2024 16:05 ET
|
Revolution Medicines, Inc.
REDWOOD CITY, Calif., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted...
Sensei Biotherapeutics to Participate in Citi’s 2024 Global Healthcare Conference
November 27, 2024 16:05 ET
|
Sensei Biotherapeutics
BOSTON, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics...
QIAGEN launches novel tools for customizing digital PCR assays and NGS panels for microbial analysis
November 27, 2024 16:05 ET
|
QIAGEN N.V.
Venlo, the Netherlands, Nov. 27, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of two new tools for designing and ordering custom solutions...
Parsons to Present at Investor Conferences
November 27, 2024 16:05 ET
|
Parsons Services Company
CHANTILLY, Va., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) announced today that Carey Smith, chair, president, and chief executive officer, and Matt Ofilos, chief financial...
- November 27, 2024 15:27 ET DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rentokil
- November 27, 2024 14:33 ET DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DENTSPLY SIRONA